 | • レポートコード：MRC2012A7631 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、前立腺がん治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。前立腺がん治療薬の種類別市場規模（ホルモン療法、化学療法、免疫療法、標的療法）、用途別市場規模（診療所、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Novartis、Johnson & Johnson、Astellas Pharma、Merck Group、Astra Zeneca、Bayer HealthCare、GlaxoSmithKline、Sanofi、Amgen、Takeda Pharmaceuticals、Boehringer Ingelheim、Ferring Pharmaceutical、Tokai Pharmaceuticals、Northwest Biotherapeutics、BMS、Janssen Pharmaceuticals、Foresee Pharmaceuticals、Teva Pharmaceutical、Endo Pharmaceuticals、Spectrum Pharmaceuticals、 ・地域別グローバル市場分析 2015年-2020年 ・前立腺がん治療薬の北米市場（アメリカ、カナダ、メキシコ） ・前立腺がん治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・前立腺がん治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・前立腺がん治療薬の南米市場（ブラジル、アルゼンチン） ・前立腺がん治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ホルモン療法、化学療法、免疫療法、標的療法 ・用途別分析：診療所、病院、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Prostate Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 7958.3 million by 2025, from USD 6256 million in 2019.
The Prostate Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prostate Cancer Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prostate Cancer Drugs market has been segmented into
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
By Application, Prostate Cancer Drugs has been segmented into:
Clinics
Hospitals
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Prostate Cancer Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Prostate Cancer Drugs Market Share Analysis
Prostate Cancer Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Cancer Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Prostate Cancer Drugs are:
AbbVie
Novartis
Johnson & Johnson
Astellas Pharma
Merck Group
Astra Zeneca
Bayer HealthCare
GlaxoSmithKline
Sanofi
Amgen
Takeda Pharmaceuticals
Boehringer Ingelheim
Ferring Pharmaceutical
Tokai Pharmaceuticals
Northwest Biotherapeutics
BMS
Janssen Pharmaceuticals
Foresee Pharmaceuticals
Teva Pharmaceutical
Endo Pharmaceuticals
Spectrum Pharmaceuticals
Among other players domestic and global, Prostate Cancer Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostate Cancer Drugs, with price, sales, revenue and global market share of Prostate Cancer Drugs in 2018 and 2019.
Chapter 3, the Prostate Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prostate Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prostate Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Prostate Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prostate Cancer Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Prostate Cancer Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Overview of Global Prostate Cancer Drugs Market
1.4.1 Global Prostate Cancer Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Astellas Pharma SWOT Analysis
2.4.4 Astellas Pharma Product and Services
2.4.5 Astellas Pharma Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck Group
2.5.1 Merck Group Details
2.5.2 Merck Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck Group SWOT Analysis
2.5.4 Merck Group Product and Services
2.5.5 Merck Group Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Astra Zeneca
2.6.1 Astra Zeneca Details
2.6.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Astra Zeneca SWOT Analysis
2.6.4 Astra Zeneca Product and Services
2.6.5 Astra Zeneca Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer HealthCare
2.7.1 Bayer HealthCare Details
2.7.2 Bayer HealthCare Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer HealthCare SWOT Analysis
2.7.4 Bayer HealthCare Product and Services
2.7.5 Bayer HealthCare Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline SWOT Analysis
2.8.4 GlaxoSmithKline Product and Services
2.8.5 GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi SWOT Analysis
2.9.4 Sanofi Product and Services
2.9.5 Sanofi Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Amgen SWOT Analysis
2.10.4 Amgen Product and Services
2.10.5 Amgen Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Takeda Pharmaceuticals
2.11.1 Takeda Pharmaceuticals Details
2.11.2 Takeda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Takeda Pharmaceuticals SWOT Analysis
2.11.4 Takeda Pharmaceuticals Product and Services
2.11.5 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Boehringer Ingelheim
2.12.1 Boehringer Ingelheim Details
2.12.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Boehringer Ingelheim SWOT Analysis
2.12.4 Boehringer Ingelheim Product and Services
2.12.5 Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ferring Pharmaceutical
2.13.1 Ferring Pharmaceutical Details
2.13.2 Ferring Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ferring Pharmaceutical SWOT Analysis
2.13.4 Ferring Pharmaceutical Product and Services
2.13.5 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Tokai Pharmaceuticals
2.14.1 Tokai Pharmaceuticals Details
2.14.2 Tokai Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Tokai Pharmaceuticals SWOT Analysis
2.14.4 Tokai Pharmaceuticals Product and Services
2.14.5 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Northwest Biotherapeutics
2.15.1 Northwest Biotherapeutics Details
2.15.2 Northwest Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Northwest Biotherapeutics SWOT Analysis
2.15.4 Northwest Biotherapeutics Product and Services
2.15.5 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 BMS
2.16.1 BMS Details
2.16.2 BMS Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 BMS SWOT Analysis
2.16.4 BMS Product and Services
2.16.5 BMS Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Janssen Pharmaceuticals
2.17.1 Janssen Pharmaceuticals Details
2.17.2 Janssen Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Janssen Pharmaceuticals SWOT Analysis
2.17.4 Janssen Pharmaceuticals Product and Services
2.17.5 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Foresee Pharmaceuticals
2.18.1 Foresee Pharmaceuticals Details
2.18.2 Foresee Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Foresee Pharmaceuticals SWOT Analysis
2.18.4 Foresee Pharmaceuticals Product and Services
2.18.5 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Teva Pharmaceutical
2.19.1 Teva Pharmaceutical Details
2.19.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Teva Pharmaceutical SWOT Analysis
2.19.4 Teva Pharmaceutical Product and Services
2.19.5 Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Endo Pharmaceuticals
2.20.1 Endo Pharmaceuticals Details
2.20.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Endo Pharmaceuticals SWOT Analysis
2.20.4 Endo Pharmaceuticals Product and Services
2.20.5 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Spectrum Pharmaceuticals
2.21.1 Spectrum Pharmaceuticals Details
2.21.2 Spectrum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Spectrum Pharmaceuticals SWOT Analysis
2.21.4 Spectrum Pharmaceuticals Product and Services
2.21.5 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prostate Cancer Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prostate Cancer Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostate Cancer Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Prostate Cancer Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prostate Cancer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Prostate Cancer Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prostate Cancer Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
4.5 South America Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prostate Cancer Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Prostate Cancer Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Prostate Cancer Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prostate Cancer Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Prostate Cancer Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prostate Cancer Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
6.3 UK Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
6.4 France Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prostate Cancer Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prostate Cancer Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
7.5 India Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prostate Cancer Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Prostate Cancer Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Prostate Cancer Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prostate Cancer Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prostate Cancer Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prostate Cancer Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prostate Cancer Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Prostate Cancer Drugs Price by Type (2015-2020)
11 Global Prostate Cancer Drugs Market Segment by Application
11.1 Global Prostate Cancer Drugs Sales Market Share by Application (2015-2020)
11.2 Global Prostate Cancer Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Prostate Cancer Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Prostate Cancer Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Prostate Cancer Drugs Market Forecast (2021-2025)
12.2.2 Europe Prostate Cancer Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prostate Cancer Drugs Market Forecast (2021-2025)
12.2.4 South America Prostate Cancer Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prostate Cancer Drugs Market Forecast (2021-2025)
12.3 Prostate Cancer Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Prostate Cancer Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Prostate Cancer Drugs Market Share Forecast by Type (2021-2025)
12.4 Prostate Cancer Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Prostate Cancer Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Prostate Cancer Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Prostate Cancer Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostate Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostate Cancer Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Prostate Cancer Drugs Major Business
Table 9. AbbVie Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Prostate Cancer Drugs Product and Services
Table 12. AbbVie Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Prostate Cancer Drugs Major Business
Table 15. Novartis Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Novartis SWOT Analysis
Table 17. Novartis Prostate Cancer Drugs Product and Services
Table 18. Novartis Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Prostate Cancer Drugs Major Business
Table 21. Johnson & Johnson Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Johnson & Johnson SWOT Analysis
Table 23. Johnson & Johnson Prostate Cancer Drugs Product and Services
Table 24. Johnson & Johnson Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 26. Astellas Pharma Prostate Cancer Drugs Major Business
Table 27. Astellas Pharma Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Astellas Pharma SWOT Analysis
Table 29. Astellas Pharma Prostate Cancer Drugs Product and Services
Table 30. Astellas Pharma Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Merck Group Basic Information, Manufacturing Base and Competitors
Table 32. Merck Group Prostate Cancer Drugs Major Business
Table 33. Merck Group Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Merck Group SWOT Analysis
Table 35. Merck Group Prostate Cancer Drugs Product and Services
Table 36. Merck Group Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 38. Astra Zeneca Prostate Cancer Drugs Major Business
Table 39. Astra Zeneca Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Astra Zeneca SWOT Analysis
Table 41. Astra Zeneca Prostate Cancer Drugs Product and Services
Table 42. Astra Zeneca Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 44. Bayer HealthCare Prostate Cancer Drugs Major Business
Table 45. Bayer HealthCare Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Bayer HealthCare SWOT Analysis
Table 47. Bayer HealthCare Prostate Cancer Drugs Product and Services
Table 48. Bayer HealthCare Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 50. GlaxoSmithKline Prostate Cancer Drugs Major Business
Table 51. GlaxoSmithKline Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 52. GlaxoSmithKline SWOT Analysis
Table 53. GlaxoSmithKline Prostate Cancer Drugs Product and Services
Table 54. GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sanofi Basic Information, Manufacturing Base and Competitors
Table 56. Sanofi Prostate Cancer Drugs Major Business
Table 57. Sanofi Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Sanofi SWOT Analysis
Table 59. Sanofi Prostate Cancer Drugs Product and Services
Table 60. Sanofi Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Prostate Cancer Drugs Major Business
Table 63. Amgen Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Amgen SWOT Analysis
Table 65. Amgen Prostate Cancer Drugs Product and Services
Table 66. Amgen Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Takeda Pharmaceuticals Prostate Cancer Drugs Major Business
Table 69. Takeda Pharmaceuticals Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Takeda Pharmaceuticals SWOT Analysis
Table 71. Takeda Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 72. Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 74. Boehringer Ingelheim Prostate Cancer Drugs Major Business
Table 75. Boehringer Ingelheim Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Boehringer Ingelheim SWOT Analysis
Table 77. Boehringer Ingelheim Prostate Cancer Drugs Product and Services
Table 78. Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Ferring Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Ferring Pharmaceutical Prostate Cancer Drugs Major Business
Table 81. Ferring Pharmaceutical Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Ferring Pharmaceutical SWOT Analysis
Table 83. Ferring Pharmaceutical Prostate Cancer Drugs Product and Services
Table 84. Ferring Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Tokai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Tokai Pharmaceuticals Prostate Cancer Drugs Major Business
Table 87. Tokai Pharmaceuticals Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Tokai Pharmaceuticals SWOT Analysis
Table 89. Tokai Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 90. Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Northwest Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Northwest Biotherapeutics Prostate Cancer Drugs Major Business
Table 93. Northwest Biotherapeutics Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Northwest Biotherapeutics SWOT Analysis
Table 95. Northwest Biotherapeutics Prostate Cancer Drugs Product and Services
Table 96. Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. BMS Basic Information, Manufacturing Base and Competitors
Table 98. BMS Prostate Cancer Drugs Major Business
Table 99. BMS Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 100. BMS SWOT Analysis
Table 101. BMS Prostate Cancer Drugs Product and Services
Table 102. BMS Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Janssen Pharmaceuticals Prostate Cancer Drugs Major Business
Table 105. Janssen Pharmaceuticals Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 106. Janssen Pharmaceuticals SWOT Analysis
Table 107. Janssen Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 108. Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Foresee Pharmaceuticals Prostate Cancer Drugs Type and Application
Table 110. Foresee Pharmaceuticals Prostate Cancer Drugs Major Business
Table 111. Foresee Pharmaceuticals Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 112. Foresee Pharmaceuticals SWOT Analysis
Table 113. Foresee Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 114. Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Teva Pharmaceutical Prostate Cancer Drugs Major Business
Table 117. Teva Pharmaceutical Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 118. Teva Pharmaceutical SWOT Analysis
Table 119. Teva Pharmaceutical Prostate Cancer Drugs Product and Services
Table 120. Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Endo Pharmaceuticals Prostate Cancer Drugs Major Business
Table 123. Endo Pharmaceuticals Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 124. Endo Pharmaceuticals SWOT Analysis
Table 125. Endo Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 126. Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Spectrum Pharmaceuticals Prostate Cancer Drugs Major Business
Table 129. Spectrum Pharmaceuticals Prostate Cancer Drugs Total Revenue (USD Million) (2017-2018)
Table 130. Spectrum Pharmaceuticals SWOT Analysis
Table 131. Spectrum Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 132. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. Global Prostate Cancer Drugs Sales by Manufacturer (2018-2019) (K MT)
Table 134. Global Prostate Cancer Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 135. Global Prostate Cancer Drugs Sales by Regions (2015-2020) (K MT)
Table 136. Global Prostate Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 137. Global Prostate Cancer Drugs Revenue by Regions (2015-2020) (USD Million)
Table 138. North America Prostate Cancer Drugs Sales by Countries (2015-2020) (K MT)
Table 139. North America Prostate Cancer Drugs Sales Market Share by Countries (2015-2020)
Table 140. North America Prostate Cancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 141. North America Prostate Cancer Drugs Revenue Market Share by Countries (2015-2020)
Table 142. Europe Prostate Cancer Drugs Sales by Countries (2015-2020) (K MT)
Table 143. Europe Prostate Cancer Drugs Sales Market Share by Countries (2015-2020)
Table 144. Europe Prostate Cancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 145. Asia-Pacific Prostate Cancer Drugs Sales by Regions (2015-2020) (K MT)
Table 146. Asia-Pacific Prostate Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 147. Asia-Pacific Prostate Cancer Drugs Revenue by Regions (2015-2020) (USD Million)
Table 148. South America Prostate Cancer Drugs Sales by Countries (2015-2020) (K MT)
Table 149. South America Prostate Cancer Drugs Sales Market Share by Countries (2015-2020)
Table 150. South America Prostate Cancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 151. South America Prostate Cancer Drugs Revenue Market Share by Countries (2015-2020)
Table 152. Middle East & Africa Prostate Cancer Drugs Sales by Countries (2015-2020) (K MT)
Table 153. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Countries (2015-2020)
Table 154. Middle East & Africa Prostate Cancer Drugs Revenue by Countries (2015-2020) (USD Million)
Table 155. Middle East & Africa Prostate Cancer Drugs Revenue Market Share by Countries (2015-2020)
Table 156. Global Prostate Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 157. Global Prostate Cancer Drugs Sales Share by Type (2015-2020)
Table 158. Global Prostate Cancer Drugs Revenue by Type (2015-2020) (USD Million)
Table 159. Global Prostate Cancer Drugs Revenue Share by Type (2015-2020)
Table 160. Global Prostate Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 161. Global Prostate Cancer Drugs Sales Share by Application (2015-2020)
Table 162. Global Prostate Cancer Drugs Sales Forecast by Regions (2021-2025) (K MT)
Table 163. Global Prostate Cancer Drugs Market Share Forecast by Regions (2021-2025)
Table 164. Global Prostate Cancer Drugs Sales Forecast by Type (2021-2025) (K MT)
Table 165. Global Prostate Cancer Drugs Market Share Forecast by Type (2021-2025)
Table 166. Global Prostate Cancer Drugs Sales Forecast by Application (2021-2025)
Table 167. Global Prostate Cancer Drugs Market Share Forecast by Application (2021-2025)
Table 168. Direct Channel Pros & Cons
Table 169. Indirect Channel Pros & Cons
Table 170. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prostate Cancer Drugs Picture
Figure 2. Global Sales Market Share of Prostate Cancer Drugs by Type in 2019
Figure 3. Hormonal Therapy Picture
Figure 4. Chemotherapy Picture
Figure 5. Immunotherapy Picture
Figure 6. Targeted Therapy Picture
Figure 7. Prostate Cancer Drugs Sales Market Share by Application in 2018
Figure 8. Clinics Picture
Figure 9. Hospitals Picture
Figure 10. Other Picture
Figure 11. Global Prostate Cancer Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Prostate Cancer Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Prostate Cancer Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Prostate Cancer Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Prostate Cancer Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Prostate Cancer Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Prostate Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Prostate Cancer Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Prostate Cancer Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Prostate Cancer Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Prostate Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Prostate Cancer Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Prostate Cancer Drugs Sales Market Share by Countries in 2018
Figure 48. North America Prostate Cancer Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Prostate Cancer Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Prostate Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Prostate Cancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Prostate Cancer Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Prostate Cancer Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Prostate Cancer Drugs Revenue Market Share by Regions 2019
Figure 64. China Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Prostate Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Prostate Cancer Drugs Sales Market Share by Countries in 2019
Figure 71. South America Prostate Cancer Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Prostate Cancer Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Prostate Cancer Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Prostate Cancer Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Prostate Cancer Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Prostate Cancer Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Prostate Cancer Drugs Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Prostate Cancer Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Prostate Cancer Drugs Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Prostate Cancer Drugs Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Prostate Cancer Drugs Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Prostate Cancer Drugs Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Prostate Cancer Drugs Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 前立腺がん治療薬の世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise…
- 前立腺がん治療の世界市場（～2026年） Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race. Market Analysis and Insights: Global Prostate Cancer Treatment Market The global Prostate Cancer Treatment market size is projected to reach US$ XX m…
- 去勢抵抗性前立腺がん治療の世界市場（～2026年） Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose a…